Related Experiment Video
Updated: Feb 27, 2026
Femoral Vascular Graft Implantation in a Swine Model to Test Small-Diameter Vascular Grafts
Published on: July 8, 2025
Long Term Outcomes of Femorofemoral Crossover Bypass Grafts
Keun-Myoung Park1, Yang-Jin Park2, Young-Wook Kim2
1Department of Surgery, Inha University Hospital, Incheon, Korea.
Insights
Femorofemoral crossover bypass (FCB) shows promising long-term results for unilateral iliac artery disease. This study demonstrates 10-year patency and limb salvage rates, supporting FCB as a viable treatment option.
Area of Science:
- Vascular Surgery
- Peripheral Artery Disease
- Iliac Artery Disease
Background:
- Femorofemoral crossover bypass (FCB) is a recognized treatment for unilateral iliac artery disease.
- Existing studies often lack extended follow-up periods, limiting understanding of long-term outcomes.
Purpose of the Study:
- To evaluate the long-term efficacy of FCB by analyzing outcomes over a 10-year follow-up period.
- To provide comprehensive data on patency and limb salvage rates for FCB in unilateral iliac artery disease.
Main Methods:
- Retrospective analysis of 133 patients undergoing FCB between January 1995 and December 2010.
- Data collected included patient characteristics, preoperative treatments, surgical procedures, and materials used.
- Median follow-up duration was 58.8 months, with a focus on 10-year outcomes.
Main Results:
- The 10-year primary patency rate was 31%, and the secondary patency rate was 67%.
- The 5-year and 10-year limb salvage rates were 97% and 95%, respectively.
- Early mortality within 30 days was low, attributed to causes other than the surgical procedure itself.
Conclusions:
- Long-term analysis indicates that FCB is a valuable alternative treatment for patients with unilateral iliac artery disease.
- The study supports the continued use of FCB for managing this condition, highlighting its durable limb salvage capabilities.
Purpose:
Femorofemoral crossover bypass (FCB) is a good procedure for patients with unilateral iliac artery disease. There are many articles about the results of FCB, but most of them were limited to 5 years follow-up. The purpose of our study was to analysis the results of FCB with a 10-year follow-up period.
Materials And Methods:
Between January 1995 and December 2010, 133 patients were operated in Samsung Medical Center (median follow-up: 58.8 months). We retrospectively analysed patient characteristics, the preoperative treatment, the operative procedure, and material used.
Results:
The indications for FCB were claudication in 110 and critical limb ischemia in 23 patients. Three patients were died due to myocardiac infarction, intracranial hemorrhage, and acute respiratory failure within 30 days after surgery. The one-year primary and secondary patency rates were 89% and 97%, the 5-year primary and secondary patency rates were 70% and 85%, and the 10-year primary and secondary patency rates were 31% and 67%. The 5-year and 10-year limb salvage rates were 97% and 95%, respectively.
Conclusion:
Our long term analysis suggests that FCB might be a valuable alternative treatment modality in patients with unilateral iliac artery disease.
More Related Videos
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
